{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:18:54Z","timestamp":1790180334500,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.euo.2023.02.013","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T07:05:32Z","timestamp":1681369532000},"page":"390-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study"],"prefix":"10.1016","volume":"6","author":[{"given":"Nicolas","family":"Benziane-Ouaritini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Ingrosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Di Staso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Trippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Francolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Marc Cosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Magne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e9mara","family":"Gnep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaelle","family":"Renard-Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewen","family":"Anger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9rane","family":"Achard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Aristei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corentin","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Zaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Detti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanguy","family":"Perennec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Mihoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Supiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Latorzeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sargos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2023.02.013_b0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ncpuro0145","article-title":"Rising prostate-specific antigen after primary prostate cancer therapy","volume":"2","author":"Ward","year":"2005","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2023.02.013_b0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II\u20142020 update: treatment of relapsing and metastatic prostate cancer","volume":"79","author":"Cornford","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.02.013_b0015","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1200\/JCO.2014.58.8525","article-title":"Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement","volume":"32","author":"Freedland","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0020","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ijrobp.2020.11.010","article-title":"Prostate bed delineation guidelines for postoperative radiation therapy: on behalf of the Francophone Group of Urological Radiation Therapy","volume":"109","author":"Robin","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2023.02.013_b0025","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/S1166-7087(20)30752-1","article-title":"Recommandations fran\u00e7aises du Comit\u00e9 de canc\u00e9rologie de l\u2019AFU \u2013 actualisation 2020\u20132022: cancer de la prostate","volume":"30","author":"Rozet","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.euo.2023.02.013_b0030","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0090-4295(02)02411-1","article-title":"Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy","volume":"61","author":"Kane","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.euo.2023.02.013_b0035","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ejrad.2011.01.095","article-title":"Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET\/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP)","volume":"81","author":"Panebianco","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.euo.2023.02.013_b0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.113.123018","article-title":"Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11 C-Choline PET\/CT with pelvic multiparametric MR imaging with endorectal coil","volume":"55","author":"Kitajima","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2023.02.013_b0045","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(21)00581-X","article-title":"18F-fluciclovine-PET\/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2\/3 randomised controlled trial","volume":"397","author":"Jani","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2023.02.013_b0050","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0360-3016(94)00475-Z","article-title":"Radiation dose-response of human tumors","volume":"32","author":"Okunieff","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2023.02.013_b0055","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s12094-019-02084-0","article-title":"Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy?","volume":"21","author":"Bruni","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fonc.2019.00012","article-title":"Disease control with delayed salvage radiotherapy for macroscopic local recurrence following radical prostatectomy","volume":"9","author":"Shelan","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.669261","article-title":"Salvage radiotherapy for macroscopic local recurrence following radical prostatectomy","volume":"11","author":"Zaine","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0070","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00330-013-2768-3","article-title":"Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging","volume":"23","author":"Panebianco","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2023.02.013_b0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.02.013_b0080","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S1470-2045(19)30486-3","article-title":"Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial","volume":"20","author":"Carrie","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0085","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1200\/JCO.2016.68.3425","article-title":"Improved metastasis-free and survival outcomes with early salvage radiotherapy in men with detectable prostate-specific antigen after prostatectomy for prostate cancer","volume":"34","author":"Stish","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0090","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1470-2045(16)00111-X","article-title":"Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial","volume":"17","author":"Carrie","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0095","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.purol.2022.07.148","article-title":"French AFU Cancer Committee guidelines\u2014update 2022\u20132024: prostate cancer\u2014diagnosis and management of localised disease","volume":"32","author":"Ploussard","year":"2022","journal-title":"Prog Urol"},{"key":"10.1016\/j.euo.2023.02.013_b0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/0284186X.2016.1223342","article-title":"Proposal for magnetic resonance imaging-guided salvage radiotherapy for prostate cancer","volume":"56","author":"Dirix","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2007.10.008","article-title":"Radiotherapy after prostatectomy: is the evidence for dose escalation out there?","volume":"71","author":"King","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2023.02.013_b0110","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41391-018-0066-5","article-title":"Use of high and very high dose radiotherapy after radical prostatectomy for prostate cancer in the United States","volume":"21","author":"Alexidis","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2023.02.013_b0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.eururo.2021.05.033","article-title":"Dose-intensified versus conventional-dose salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: the SAKK 09\/10 randomized phase 3 trial","volume":"80","author":"Ghadjar","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.02.013_b0120","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijrobp.2019.09.047","article-title":"Toxicity and biochemical outcomes of dose-intensified postoperative radiation therapy for prostate cancer: results of a randomized phase III trial","volume":"106","author":"Qi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2023.02.013_b0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/COC.0000000000000130","article-title":"Results of dose-adapted salvage radiotherapy after radical prostatectomy based on an endorectal MRI target definition model","volume":"40","author":"Zilli","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0130","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2023.02.013_b0135","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0145","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(20)31952-8","article-title":"Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data","volume":"396","author":"Vale","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2023.02.013_b0150","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1200\/JCO.2006.09.6495","article-title":"Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794","volume":"25","author":"Swanson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0155","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","article-title":"Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy","volume":"25","author":"Stephenson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.02.013_b0160","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.eururo.2014.09.019","article-title":"Nomogram predicting prostate cancer\u2013specific mortality for men with biochemical recurrence after radical prostatectomy","volume":"67","author":"Brockman","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.02.013_b0165","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ejca.2011.08.013","article-title":"Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling","volume":"48","author":"Ohri","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euo.2023.02.013_b0170","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2967\/jnumed.118.220103","volume":"60","author":"Emmett","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2023.02.013_b0175","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2967\/jnumed.118.225185","article-title":"The contribution of multiparametric pelvic and whole-body MRI to interpretation of 18 F-fluoromethylcholine or 68 Ga-HBED-CC PSMA-11 PET\/CT in patients with biochemical failure after radical prostatectomy","volume":"60","author":"Metser","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2023.02.013_b0180","first-page":"125","article-title":"Detection of local recurrence with 3-Tesla MRI after radical prostatectomy: a useful method for radiation treatment planning?","volume":"32","author":"Buergy","year":"2018","journal-title":"In Vivo"},{"key":"10.1016\/j.euo.2023.02.013_b0185","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.euo.2021.01.003","article-title":"Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international consensus-based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy","volume":"4","author":"Panebianco","year":"2021","journal-title":"Eur Urol Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123000676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123000676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:48:55Z","timestamp":1762876135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931123000676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2588931123000676"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2023.02.013","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2023.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}